The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments.
about
Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's diseaseElectronic cigarettes for smoking cessation and reductionElectronic cigarettes for smoking cessation and reductionNicotine chemistry, metabolism, kinetics and biomarkersEmerging drugs for the treatment of tobacco dependence: 2014 updateComprehensive review of epidemiological and animal studies on the potential carcinogenic effects of nicotine per seA systematic review of possible serious adverse health effects of nicotine replacement therapy.Nicotine: specific role in angiogenesis, proliferation and apoptosis.Nicotine signaling and progression of chronic kidney disease in smokers.Smoking cessation pharmacotherapy--nicotine and non-nicotine preparations.Neuroanatomical circuitry mediating the sensory impact of nicotine in the central nervous systemEvaluation of a novel nicotine inhaler device: part 2--effect on craving and smoking urges.Evaluation of a novel nicotine inhaler device: part 1--arterial and venous pharmacokinetics.Therapeutic options and challenges for substances of abuse.A prospective study of off-label use of, abuse of, and dependence on nicotine inhaler.Nicotine Induces Podocyte Apoptosis through Increasing Oxidative Stress.Nicotine delivery systems.The use of the nicotine inhaler in smoking cessation.Brain β2*-nicotinic acetylcholine receptor occupancy after use of a nicotine inhaler.Nicotine delivery to rats via lung alveolar region-targeted aerosol technology produces blood pharmacokinetics resembling human smokingWhich is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?Evaluation of electronic cigarette use (vaping) topography and estimation of liquid consumption: implications for research protocol standards definition and for public health authorities' regulationEffects of nicotine during pregnancy: human and experimental evidence.Smoking cessation pharmacotherapy.Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatment.A systematic review of nicotine by inhalation: is there a role for the inhaled route?Gateway effects and electronic cigarettes.Evaluation of Nicotine Pharmacokinetics and Subjective Effects following Use of a Novel Nicotine Delivery System.Combination Nicotine Metered Dose Inhaler and Nicotine Patch for Smoking Cessation: A Randomized Controlled Trial.An update on the pharmacotherapeutic interventions for smoking cessation.Assessing Discrimination of Nicotine in Humans Via Cigarette Smoking.An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion.The role of nicotine content information in smokers' subjective responses to nicotine and placebo inhalers.Acute electronic cigarette use: nicotine delivery and subjective effects in regular users.Smoking cessation post-discharge following nicotine replacement therapy use during an inpatient admission.Craving control using nicotine replacement therapy in a teaching hospital.Commentary on Wagener et al. (2012): electronic cigarettes - the Holy Grail of nicotine replacement?Tackling student binge drinking: Pairing incongruent messages and measures reduces alcohol consumption.Methadone is a non-competitive antagonist at the α4β2 and α3* nicotinic acetylcholine receptors and an agonist at the α7 nicotinic acetylcholine receptor.Histone hypo-acetylation of Sox9 mediates nicotine-induced weak cartilage repair by suppressing BMSC chondrogenic differentiation.
P2860
Q21131066-B474E9FB-39AE-483C-BB52-5BBCC238F3C4Q24187273-DD64D826-802A-4001-AC8D-23F2072B4B43Q24197756-B5C6A569-D2D8-4C77-A0FF-7714962AB37CQ24632647-250D0643-FB26-44D7-A023-54E146F62500Q28236453-603527E3-5671-4768-AC8E-FEF42267EA43Q28830476-D304477A-6848-4D7D-B84B-1434E907AEFFQ30244886-31239305-A8D4-4021-B60D-CABFA9A135C1Q34229828-3F88BD8D-DA53-4012-B55F-28B9B5AA2187Q34360219-25A5FF4A-92AC-4B4A-95A7-792E3B99D284Q34613937-865C6673-8DDC-4607-94C5-100D94A256F9Q34734457-76D87B17-3C1A-47FB-9D75-339AF787FCF2Q34803630-1FD1B8E9-2CDA-4122-B07B-4C26A2C51019Q34803642-D1EAE32E-737F-49C0-9F5C-C04A6C045B4EQ35454891-5ABF5DD0-6769-498C-87B8-ED498CE9B3BAQ35539274-A53609BE-87A6-4D59-BF53-975C4DF541C6Q36209753-9E182015-8CB8-4824-80F2-2C02DD077ED1Q36316803-B7CAE940-D58A-4327-B1F6-3E2F5BAC2577Q36405643-E11D966B-4A00-47E2-9931-5F2D8BD3EB2BQ36433744-EC6A8105-753C-4FBA-84D6-DB63AA0F2A6DQ36929845-E2DCAD16-10E6-4B14-B96E-674825493AC9Q37000723-839805DE-8FD4-441C-94CB-4FE1B4018D67Q37030804-6FED6A7F-0B27-4780-BD20-43A416668C36Q37131130-992C9E05-1F69-483A-8B29-61A1A3659120Q37505737-6EC19445-B66D-4504-8166-1B510A5BBB98Q37603891-90A68287-929D-4822-9250-44A3FD502614Q37989379-2B596F2B-1C6B-4456-A4E1-5A024400876BQ38635404-2E2B4E55-8B1E-4901-B632-E009E979FE54Q38798057-DBF9EB2F-E256-4301-8502-C7EA13965C68Q38836023-13B75316-621E-4783-917F-B50F22775E08Q38856723-7DFF4E3C-8D3D-4517-AECC-0C5572547D56Q38890394-A445DF3F-BE68-4AE5-B2E7-448AD0052AE9Q39248772-40727A9B-4586-4A13-97B4-93B31C2EF8DEQ39271325-2B1D8529-FE20-43A1-851E-0722896E7ACFQ39361094-A6FC8AAE-7321-4EB3-946F-366D6248537CQ44805475-C1BB6F79-9934-467B-BC8F-EEE6CFF7F703Q48222398-E3535045-BFD7-4A1D-999B-5A7E3A44943AQ49180180-95CFCA55-8FC2-4CAB-B69B-357809884295Q51824516-6EB6D4E3-2C44-456A-B4E6-36DEECCD69B7Q52305450-322D649C-DA98-410C-84D4-5EB6DA9C1701Q54967098-FBA89175-817C-43F9-8166-44EA9FB382C0
P2860
The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The nicotine inhaler: clinical ...... ith other nicotine treatments.
@ast
The nicotine inhaler: clinical ...... ith other nicotine treatments.
@en
The nicotine inhaler: clinical ...... ith other nicotine treatments.
@nl
type
label
The nicotine inhaler: clinical ...... ith other nicotine treatments.
@ast
The nicotine inhaler: clinical ...... ith other nicotine treatments.
@en
The nicotine inhaler: clinical ...... ith other nicotine treatments.
@nl
prefLabel
The nicotine inhaler: clinical ...... ith other nicotine treatments.
@ast
The nicotine inhaler: clinical ...... ith other nicotine treatments.
@en
The nicotine inhaler: clinical ...... ith other nicotine treatments.
@nl
P2093
P2860
P1476
The nicotine inhaler: clinical ...... ith other nicotine treatments.
@en
P2093
Franzon MA
Olmstead RE
Schneider NG
P2860
P304
P356
10.2165/00003088-200140090-00003
P577
2001-01-01T00:00:00Z
P5875
P6179
1017423455